Showing results (971-980 of 1,057) with videos related to

Sort By:
Pageof 106
Scientific Reports|August 20, 2021
Plasma fibrinogen, D-dimer, and fibrin degradation product as biomarkers of rheumatoid arthritisLi Xue, Li Tao, Xueyi Li, et al.
Veterinary Microbiology|March 5, 2019
Novel variant strains of infectious bursal disease virus isolated in ChinaLinjin Fan, Tiantian Wu, Altaf Hussain, et al.
Plos Pathogens|February 7, 2024
N123I mutation in the ALV-J receptor-binding domain region enhances viral replication ability by increasing the binding affinity with chNHE1Mengmeng Yu, Yao Zhang, Li Zhang, et al.
Transboundary and Emerging Diseases|April 30, 2025
A Single Mutation of VP2 is Responsible for the Lethality and Antigenicity Differences between Novel Variant and Very Virulent IBDV StrainsNan Jiang, Guodong Wang, Wenying Zhang, et al.
The Journal of Biological Chemistry|September 22, 2024
Identification of Cables1 as a critical host factor that promotes ALV-J replication via genome-wide CRISPR/Cas9 gene knockout screeningPeng Liu, Jinghua Jiang, Yuntong Chen, et al.
International Journal of Antimicrobial Agents|September 27, 2023
Enterococcus faecium C171: Modulating the Immune Response to Acute Lethal Viral ChallengeJielan Mi, Tana He, Xinyun Hu, et al.
International Journal of Biological Macromolecules|August 13, 2025
Development of a neutralizing monoclonal antibody to differentiate the predominant epidemic novel variant IBDV (nVarIBDV) from very virulent IBDV (vvIBDV)Guodong Wang, Wenying Zhang, Hangbo Yu, et al.
Veterinary Sciences|March 27, 2026
Identification of a Novel Antigenic Epitope in Envelope Protein of Avian Reticuloendotheliosis VirusJingzhe Han, Mengmeng Huang, Guodong Wang, et al.
Journal of Virology|October 27, 2017
Residues 28 to 39 of the Extracellular Loop 1 of Chicken Na<sup>+</sup>/H<sup>+</sup> Exchanger Type I Mediate Cell Binding and Entry of Subgroup J Avian Leukosis VirusXiaolu Guan, Yao Zhang, Mengmeng Yu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 7, 2017
Combination Therapy with NHS-muIL12 and Avelumab (anti-PD-L1) Enhances Antitumor Efficacy in Preclinical Cancer ModelsChunxiao Xu, Yanping Zhang, P Alexander Rolfe, et al.
Pageof 106